IDEXX Laboratories, Inc. vs Zoetis Inc. — Stock Comparison
IDEXX Laboratories, Inc. (IDXX) and Zoetis Inc. (ZTS) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
IDEXX Laboratories, Inc. scores ahead of Zoetis Inc. on Q·Score (7.9 vs 6.9 out of 10), led by Growth (7.9 vs 4.6) and Valuation (7.9 vs 7.1). Zoetis Inc. scores higher on Quality, reflecting stronger profitability and returns. Analyst consensus targets imply greater upside for IDXX (+35.4%) than for ZTS (+28.3%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
High-quality business with 74% return on equity and 25% profit margins.
High-quality business with 65% return on equity and 28% profit margins.
⚠ revenue declining 0% year-over-year.
Analyst Consensus
Fundamentals
Frequently Asked Questions
IDXX vs ZTS: which stock scores better overall?
Based on Q·Score, IDEXX Laboratories, Inc. (IDXX) scores 7.9/10 versus Zoetis Inc. (ZTS) at 6.9/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: IDXX or ZTS?
IDEXX Laboratories, Inc. (IDXX) scores higher on Growth (7.9/10 vs 4.6/10). IDEXX Laboratories, Inc. reports revenue growth (9.7% YoY) while Zoetis Inc. reports (-0.2% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is IDXX or ZTS more attractively valued?
IDEXX Laboratories, Inc. (IDXX) scores higher on Valuation (7.9/10 vs 7.1/10). IDXX trades at 30.9× P/E versus ZTS at 11.4×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about IDXX vs ZTS?
There are 12 analysts covering IDXX with a consensus price target of $701.33, and 14 analysts covering ZTS with a consensus target of $96.00. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: IDXX or ZTS?
Zoetis Inc. (ZTS) scores higher on Quality (9.6/10 vs 9.3/10). Net profit margin: IDXX at 25.0%, ZTS at 27.7%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: IDXX or ZTS?
IDEXX Laboratories, Inc. (IDXX) scores higher on Financial Health (7/10 vs 6.2/10). Market beta: IDXX at 1.55, ZTS at 0.74. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of IDXX and ZTS?
IDEXX Laboratories, Inc. (IDXX) has a market capitalisation of $40.8B, while Zoetis Inc. (ZTS) has a market cap of $30.9B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do IDXX or ZTS pay dividends?
IDXX does not currently pay a dividend, while ZTS pays a dividend yield of 2.83%. Dividend yields fluctuate with share price and company payout decisions.
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →